169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof
#1202CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#1203BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE
#1204METHOD AND KIT FOR QUANTIFYING LIVER-TYPE FATTY ACID BINDING PROTEIN, METHOD AND KIT FOR TESTING FOR KIDNEY DISEASES, AND COMPANION DIAGNOSTIC DRUG
#1205PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FABRY DISEASE, CONTAINING TSP1 PROTEIN INHIBITOR AS ACTIVE INGREDIENT
#1206Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
#1207Diagnostic methods, therapeutic agents and uses thereof
#1208Method for Detecting Liver Diseases
#1209ANTIBODIES THAT BIND TO NATIVELY FOLDED MYOCILIN
#1210Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#1211Marker for diagnosing atherosclerosis severity, and diagnostic method using same
#1212SYSTEM FOR DETERMINING PERITONITIS USING HOMODIMER NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN
#1213METHOD OF SIMULTANEOUSLY DIAGNOSING ACTIVE TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION USING HUMAN WHOLE BLOOD SAMPLE-DERIVED BIOMARKER
#1214METHODS OF DETECTING MARKERS FOR INFLAMMATORY CONDITIONS AND FOOD SENSITIVITY IN COMPANION ANIMALS
#1215USE OF GILZ AS A BIOMARKER IN SEPSIS
#1216METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT
#1217DETERMINATION OF PARKINSON'S DISEASE
#1218USE OF CD26 AND CD39 AS NEW PHENOTYPIC MARKERS FOR ASSESSING MATURATION OF FOXP3+ T CELLS AND USES THEREOF FOR DIAGNOSTIC PURPOSES
#1219Method and kit for the detection of pancreatic dysfunction
#1220Method for the Diagnosis of Gaucher's Disease
#1221Protein signatures for distinguishing between bacterial and viral infections
#1222COMPOSITIONS AND METHODS OF PROGNOSIS AND CLASSIFICATION FOR PREECLAMPSIA
#12233-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#1224METHODS FOR TARGETED ASSESSMENT AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ACUTE EVENTS AND MORTALITY ASSOCIATED THEREWITH
#1225CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS
#1226Vascular occlusion testing device
#1227METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS
#1228BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS
#1229Fluid actuation of instruments through a sterile barrier
#1230Human antibody having high affinity to human IL-4 receptor alpha
#1231COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF
#1232Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
#1233METHODS FOR TREATING CARDIAC INJURY
#1234METHOD FOR FUNCTIONAL CHARACTERISTICS OF PROTEINS FOR CLASSIFICATION OF PATIENTS TO BE ASSOCIATED TO A SPECIFIC DISEASE
#1235Method for Predicting Prognosis of Ischemic Disease
#1236MARKERS OF RISK TO DEVELOP INSULIN RESISTANCE DURING CHILDHOOD AND YOUNG ADULTHOOD
#1237BLOOD-BASED SIGNATURES FOR DIAGNOSIS AND SUB-TYPING OF INFLAMMATORY BOWEL DISEASE SUBSETS
#1238Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
#1239Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
#1240GDF15 in glaucoma and methods of use thereof
#1241Method for Diagnosing Intermittent Claudication and Chronic Limb-Threatening Ischemia
#1242NON-INVASIVE APPROACH TO EARLY DIAGNOSIS AND PROGNOSIS OF ACUTE SEVERE PANCREATITIS BASED ON HEAT SHOCK PROTEINS MECHANISM OF ACTION
#1243Compositions and methods for using cross-dressing to enhance anti-tumor immune responses
#1244COMPOSITION FOR PREVENTING OR TREATING KELOIDS OR HYPERTROPHIC SCARS
#1245ANTIBODIES SPECIFIC FOR GLYCOSYLATED APOJ AND USES THEREOF
#1246COMPOSITIONS AND METHODS FOR IDENTIFYING SUBJECTS AT RISK FOR TRAUMATIC BRAIN INJURY
#1247BIOMARKERS FOR MITOCHONDRIAL DISEASES AND RELATED METHODS
#1248DIAGNOSTIC BIOMARKERS FOR SHRIMP ALLERGY
#1249DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS
#1250Anti-mesothelin binding proteins
#1251ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
#1252Biomarker of polycystic kidney disease and uses thereof
#1253Noninvasive method to quantify kidney function and functional decline
#1254Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist
#1255Glomerulonephritis biomarkers
#1256Spectroscopic biological material characterization
#1257Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#1258Calibrator, complex, and method for measuring IgA aggregate
#1259TGF- RECEPTOR II ISOFORM, FUSION PEPTIDE, METHODS OF TREATMENT AND METHODS IN VITRO
#1260MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#1261Identification of PPM1D mutations as a novel biomarker for NAMPTi sensitivity
#1262USE OF SOLUBLE TREM-1 LEVELS FOR IDENTIFYING SUBJECTS SUSCEPTIBLE TO RESPOND TO AN ANTI-INFLAMMATORY THERAPY
#1263In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
#1264METHOD, ARRAY AND USE FOR DETERMINING THE PRESENCE OF PANCREATIC CANCER
#1265Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
#1266A METHOD OF DIAGNOSING OR PROGNOSING PSORIATIC ARTHRITIS
#1267Methods of Treating Cancer
#1268Anti-tenascin C antibodies and uses thereof
#1269IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY
#1270METABOLIC BIOMARKERS OF NAFLD/NASH AND RELATED DISEASE PHENOTYPES AND METHODS OF USING SAME
#1271COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES
#1272tTG-DGP BIOMARKERS FOR MONITORING CELIAC DISEASE
#1273NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCIES, CYSTINOSIS, AND WILSON DISEASE
#1274Rheumatoid arthritis auto-antibody-bound peptide and application thereof
#1275EGFR blocking agents for the therapeutic treatment of myopia
#1276Recombinant antibody against human cardiac troponin I
#1277SARS-COV-2 N PROTEIN AND METHODS OF USE
#1278COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY
#1279METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION
#1280Methods of detecting and treating airway inflammatory diseases
#1281Device and methods
#1282Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#1283Lck AS A THERAPEUTIC TARGET IN IDIOPATHIC PULMONARY FIBROSIS
#1284DYSREGULATION OF COVID-19 RECEPTOR ASSOCIATED WITH IBD
#1285Compounds, compositions and methods
#1286Treatment of circadian rhythm disorders
#1287BIOMARKERS AND TEST MODELS FOR CHRONIC KIDNEY DISEASE
#1288Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
#1289SARS-COV-2 infection biomarkers and uses thereof
#1290Cell atlas of the healthy and ulcerative colitis human colon
#1291ANALYTIC METHOD AND KIT FOR DIAGNOSING ALCOHOL USE DISORDERS
#1292Dosage regimen for MAdCAM antagonists
#1293COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING A GROWTH RELATED DISEASE AND/OR A CLINICAL CONDITION THEREOF
#1294EGG ALLERGY ANTIGEN
#1295Stress test and treatment of chronic kidney disease
#1296System and Method for Tracking Infectious Disease
#1297Biomarkers for Precisely Predicting the Glomerular Filtration Rate and for Indicating Pathophysiologic Factors of an Impaired Glomerular Filtration Rate
#1298METHODS FOR TREATING AORTIC ANEURYSM DISEASE
#1299COMBINATORIAL ANTIBODY DIAGNOSTIC
#1300Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#1301LSD dose identification
#1302NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME
#1303ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF
#1304Detection of glutathionylated proteins
#1305Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
#1306Non-human animals models of retinoschisis
#1307COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG FUNCTION
#1308Biomarker for thoracic aortic aneurysm
#1309TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
#1310Method, Systems, and a Kit for Detection, Diagnosis, Monitoring and Treatment of COVID-19
#1311PRO-ADM FOR PROGNOSING THE RISK OF A MEDICAL CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE
#1312BIOMARKERS AND CLASSIFICATION ALGORITHMS FOR CHRONIC KIDNEY DISEASE IN CATS
#1313BACTERIAL VAGINOSIS DIAGNOSTIC
#1314Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1315Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1316Methods for enabling pet ownership
#1317Devices, systems, and methods for measuring biomarkers in biological fluids
#1318PROADM AND/OR HISTONES AS MARKERS INDICATING AN ADVERSE EVENT
#1319A METHOD FOR DIFFERENTIALLY DIAGNOSING IN VITRO A BIPOLAR DISORDER AND A MAJOR DEPRESSIVE DISORDER
#1320DIAGNOSTIC METHODS FOR LIVER DISORDERS
#1321PROTEOMIC SCREENING FOR DISEASES
#1322Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#1323Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
#1324Protein biomarkers for diseases associated with the contact activation system
#1325PRO-ADRENOMEDULLIN OR FRAGMENT THEREOF IN PATIENTS INFECTED WITH CORONA VIRUS AND TREATMENTS WITH BINDER AGAINST ADRENOMEDULLIN
#1326DEVICE AND METHODS
#1327Anti-CD59 antibodies
#1328Methods and compositions for treating asthma and allergic diseases
#1329Compositions and methods for identifying and modulating metabolic health
#1330METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASE
#1331Targeted HD5 antibody and assay methods for diagnosing and treating inflammatory bowel disease
#1332GUT MICROBIOME FUNCTION PREDICTS RESPONSE TO ANTI-INTEGRIN BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASES
#1333DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
#1334PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
#1335Immune Monitoring of Neuro-Inflammatory Amyotrophic Lateral Sclerosis (ALS)
#1336IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN
#1337Anti-PD-L1 antibodies
#1338Methods and Compositions for Regulating an Immune Response
#1339APPARATUS AND METHODS FOR DISEASE DETECTION AND TREATMENT
#1340Composition for diagnosing allergies to mites, method of diagnosing allergies to mites, and composition for preventing or treating allergies to mites
#1341BIOMARKER, METHODS, AND COMPOSITIONS THEREOF FOR EVALUATION OR MANAGEMENT OF KIDNEY FUNCTION OR DIAGNOSING OR AID IN DIAGNOSING KIDNEY DYSFUNCTION OR KIDNEY DISEASE
#1342Antibodies and Immunoassays for Detection of BMP-15 and GDF-9 Isoforms
#1343ZnT8 assays for drug development and pharmaceutical compositions
#1344QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
#1345PREDICTING MORTALITY AND DETECTING SEVERE DISEASE
#1346PREDICTION OF DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS
#1347METHODS FOR OBJECTIVE ASSESSMENT OF STRESS, EARLY DETECTION OF RISK FOR STRESS DISORDERS, MATCHING INDIVIDUALS WITH TREATMENTS, MONITORING RESPONSE TO TREATMENT, AND NEW METHODS OF USE FOR DRUGS
#1348METHOD FOR DETERMINING DECREASE IN FUNCTIONS OF HIPPOCAMPUS BY USING CORRELATION BETWEEN MICRO RNA AND NMDA RECEPTOR, METHOD FOR INHIBITING DECREASE IN FUNCTIONS, AND METHOD FOR SCREENING FOR INHIBITORS OF DECREASE IN FUNCTIONS
#1349Serine protease inhibitor kazal (SPIK) compositions and methods
#1350NOVEL THERAPY
#1351Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
#1352TETZ-PROTEINS AND PRION-LIKE PROTEINS AND ASSOCIATED METHODS
#1353NOVEL BIOMARKERS FOR RECURRENT TONSILLITIS
#1354Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#1355COMPLEMENT C4D ASSAY
#1356FLUID ACTUATION OF INSTRUMENTS THROUGH A STERILE BARRIER
#1357Crystal structure of a replication protein encoded by a plasmid isolated from a multiple sclerosis patient
#1358NON-INVASIVE SYSTEM FOR CALCULATING A HUMAN OR ANIMAL, RELIABLE, STANDARDIZED AND COMPLETE SCORE
#1359ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION
#1360TEST METHOD FOR OLFACTORY MUCOSA OR OLFACTORY MUCUS IN MAMMALS
#1361SYNERGISTIC COMBINATION OF BIOMARKERS FOR DETECTING AND ASSESSING HEPATIC FIBROSIS
#1362CIRCULATING FGFBP-1 (FIBROBLAST GROWTH FACTOR-BINDING PRO-TEIN 1) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND FOR THE PREDICTION OF STROKE
#1363BIOMARKERS FOR EARLY DIAGNOSIS OF CHRONIC HIP DISPLASIA AND METHODS OF USING THE SAME
#1364Glucose transporter 4 antibodies, methods of making the same, and uses thereof
#1365INTERACTIVE COMPUTING SYSTEM TO GENERATE CUSTOMIZED PREVENTIVE HEALTH INFORMATION BASED ON AN INDIVIDUAL'S BIOMARKERS
#1366VITAMIN D BINDING PROTEIN IN THE CLINICAL MANAGEMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
#1367COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#1368Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers for early detection of sepsis
#1369COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE IN SELECTED PATIENTS
#1370Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers
#1371Transthyretin antibodies and uses thereof
#1372NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING
#1373PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS
#1374METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#1375METHODOLOGIES AND METHODS FOR MEASURING HIGHER MOLECULAR WEIGHT TRANSTHYRETIN OR EQUIVALENTS AS A CLINICAL BIOMARKER
#1376Methods for prognosing crohn's disease comprising human defensin 5 (HD5)
#1377DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS
#1378Bleomycin for mimicking the effect of ionizing radiations on T cells
#1379IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#1380METHODS FOR DIAGNOSING, PROGNOSING AND MONITORING TREATMENT FOR THROMBOSIS IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
#1381METHOD OF DIAGNOSIS OF LIVER STEATOSIS
#1382Sustained Response Predictors After Treatment with Anti-IL23 Antibody
#1383CIRCULATING SPON-1 (SPONDIN-1) IN THE ASSESSMENT OF ATRIAL FIBRILLATION
#1384TEST STRIP WITH STRUCTURED SUBSTRATE FOR MULTIPLEX LATERAL FLOW ASSAY FOR DISEASE DIAGNOSTICS
#1385COMPLEMENT ALTERNATIVE PATHWAY-ASSOCIATED NEPHROPATHY BIOMARKERS
#1386CANCER LESION TISSUE EVALUATION FOR OPTIMIZING EFFECT OF BORON NEUTRON CAPTURE THERAPY
#1387Serum biomarkers for predicting and evaluating response to TNF inhibitor therapy in rheumatoid arthritis patients
#1388Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof
#1389PROTEIN BIOMARKERS FOR NEPHROPATHY AND APPLICATIONS THEREOF
#1390Method and means for diagnosing and treating allergy
#1391ICOSL for use as a Renal Therapeutic
#1392DOWN SYNDROME BIOMARKERS AND USES THEREOF
#1393Method for diagnosis and/or prognosis of a septic syndrome
#1394Treatment of circadian rhythm disorders
#1395Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
#1396FARBER DISEASE MARKERS AND USES THEREOF
#1397Protein and gene biomarkers for rejection of organ transplants
#1398Use of ZC3H12B gene or protein and method for establishing animal model of liver disease
#1399IDENTIFICATION OF SPATIAL BIOMARKERS OF HEART DISORDERS AND METHODS OF USING THE SAME
#1400Methods for diagnosing and assessing risk of developing glomerulosclerosis
#1401ANTIFIBROTIC AGENT AND BIOMARKER FOR FIBROSIS
#1402Neuropilin-1 Specific Binding Peptides and its Fusion Protein, and Use Thereof
#1403CIRCULATING BMP10 (BONE MORPHOGENIC PROTEIN 10) IN THE ASSESSMENT OF ATRIAL FIBRILLATION
#1404Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#1405METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#1406Methods and reagents for diagnosis of SARS-CoV-2 infection
#1407Method for detecting castration-resistant prostate cancer and detection reagent
#1408Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#1409Antibodies against HPA-1a
#1410Anti-transthyretin antibodies
#1411CIRCULATING TFPI-2 (TISSUE FACTOR PATHWAY INHIBITOR 2) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND ANTICOAGULATION THERAPY
#1412HEALTH TEST FOR A BROAD SPECTRUM OF HEALTH PROBLEMS
#1413Classification of periodontitis patients
#1414Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
#1415TTP phosphorylation as a biomarker in targeted therapy
#1416CES-2 (CARBOXYLESTERASE-2) FOR THE ASSESSMENT OF AFIB RELATED STROKE
#1417METHOD
#1418METHOD FOR ANALYSIS OF CHONDROITIN SULFATE
#1419Inhibitor of IGFBP3/TMEM219 Axis and Diabetes
#1420METHOD FOR MEASURING THE TRIMETHYLAMINE N-OXIDE PRODUCTION CAPACITY IN AN INDIVIDUAL
#1421Discriminating Parkinson's disease from multiple system atrophy using alpha-synuclein PMCA
#1422HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE
#1423PERIODONTITIS DIAGNOSTIC METHODS, USES AND KITS
#1424GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS
#1425METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#1426Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm and Hookworm
#1427DEVICES AND METHODS FOR DIAGNOSIS OF SINUSITIS
#1428Methods of Treating Cardiovascular Diseases and Predicting the Efficacy of Exercise Therapy
#1429Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
#1430REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT SCREENING METHOD, AND REFRACTORY ASTHMA PROPHYLACTIC/THERAPEUTIC AGENT
#1431Anti-TIM-3 antibodies
#1432Treatment of severe community acquired pneumonia
#1433Treatment of circadian rhythm disorders
#1434CIRCULATING DKK3 (DICKKOPF-RELATED PROTEIN 3) IN THE ASSESSMENT OF ATRIAL FIBRILLATION
#1435Methods for quantifying frataxin activity
#1436METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1437METHODS AND DEVICES FOR MULTI-STEP CELL PURIFICATION AND CONCENTRATION
#1438METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1439TREATMENTS AND BIOMARKERS FOR THE PROGNOSIS OF ZIKA VIRUS INFECTION
#1440DIAGNOSTICS OF MILD OR ADVERSED PERIODONTITIS
#1441METHOD OF DETECTING HEART FAILURE, DEVICE FOR DETECTING HEART FAILURE, SANDWICH IMMUNOASSAY METHOD, AND COMBINATION OF ANTIBODIES
#1442METHODS AND ASSAYS FOR USE IN DIAGNOSIS OF LAMINITIS
#1443METHOD FOR MEASURING SERUM AMYLOID A OF VARIOUS ANIMALS AND REAGENT FOR MEASUREMENT THEREOF
#1444Compositions and methods for predicting post-surgical cardiovascular events
#1445Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10)
#1446Biomarkers For Endometriosis
#1447COMPOSITIONS AND METHODS ASSOCIATED WITH HAPTOGLOBIN RELATED PROTEIN
#1448METHOD OF DIAGNOSING PERIODONTAL CONDITIONS USING SALIVARY PROTEIN MARKERS
#1449METHOD AND APPARATUS FOR MONITORING THE STATE OF HEALTH OF DAIRY COWS
#1450A THREE-PROTEIN PROTEOMIC BIOMARKER FOR PROSPECTIVE DETERMINATION OF RISK FOR DEVELOPMENT OF ACTIVE TUBERCULOSIS
#1451Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications
#1452Compositions, methods and kits for treating complement related disorders
#1453Biomarkers for Diagnosis and Prognosis of Corneal Ectatic Disorders
#1454METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#1455Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof
#1456MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA AND PREGNANCY
#1457Isolated organ evaluation and treatment
#1458Q-peptide hydrogel promotes immune modulation and macrophage differentiation
#1459MICRO-ORGANISMAL PRODUCT AND METHOD FOR TREATING SICKLE CELL DISEASE
#1460BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASE
#1461Biomarkers for graft-versus-host disease
#1462Method for quantification of amino acids using cell-free protein synthesis system
#1463Pencil-like optical fiber sensor probe, portable immunosensor and use thereof
#1464DIABETES-RELATED BIOMARKERS AND TREATMENT OF DIABETES-RELATED CONDITIONS
#1465BIOMARKER FOR PREDICTING EFFECTIVENESS FOR AUTOIMMUNE DISEASE TREATMENT, DIAGNOSTIC KIT, AND USE FOR TREATMENT
#1466Methods and Compositions for the Diagnosis and Treatment of Kawasaki Disease
#1467VARIANT LIBRARIES OF THE IMMUNOLOGICAL SYNAPSE AND SYNTHESIS THEREOF
#1468HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
#1469COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
#1470METHODS FOR TREATING CHOLESTASIS
#1471DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#1472PERIODONTITIS DIAGNOSTIC METHODS, USES AND KITS
#1473Method of treating and prognosing scoliotic patient subgroups
#1474Anti-presepsin antibody
#1475HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF
#1476USE OF GFAP FOR IDENTIFICATION OF INTRACEREBRAL HEMORRHAGE
#1477SYSTEM AND METHOD FOR DETERMINING LUNG HEALTH
#1478METHODS FOR THE PREDICTION OF A PERSONALIZED ESA-DOSE IN THE TREATMENT OF ANEMIA
#1479Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
#1480METHOD, SYSTEM AND APPARATUS FOR SUBSTANCE IDENTIFICATION
#1481Diagnosis of sepsis
#1482Analyte Detection method
#1483METHODS FOR PREVENTING ACUTE KIDNEY INJURY
#1484Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1485Urine markers and formula for diagnosing overactive bladder disorder
#1486BLOOD BIOMARKER FOR EOSINOPHILIC GASTROINTESTINAL DISORDERS
#1487MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS
#1488Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
#1489Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#1490Diagnostic methods for cardiovascular diseases
#1491Methods and materials for assessing and treating obesity
#1492ANTI-C5AR ANTIBODY AND PREPARATION METHOD AND USE THEREOF
#1493Treatment of pyroptosis
#1494Compositions and methods for identifying and treating dystonia disorders
#1495APPLICATIONS OF BIOMARKER IN TERMS OF DETERMINING ANTIPHOSPHOLIPID SYNDROME AND REAGENT KIT OF BIOMARKER
#1496METHODS FOR PREVENTING AND/OR TREATING BONE LOSS CONDITIONS BY MODULATING IRISIN
#1497Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers
#1498Dissolved protein arthritis markers
#1499Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1500CD47 monoclonal antibodies and uses thereof